510(k) Report

510(k) · Cleared

Cleared

Deep TMS System

K222196510(k) TraditionalCleared May 31, 2024679-day reviewClass II21 CFR 882.5805

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Brainsway, Ltd. · OBP Transcranial Magnetic Stimulator

Cleared on May 31, 2024 as substantially equivalent to K210201 (Brainsway, Ltd., 2021) after a 679-day review. Its family tree reaches back 5 generations to 2008. 2 later devices descend from it.

Decided
May 31, 2024
Review
679 days
Class
Class II
Product code
OBP
Recalls
None
Predicates
1

Its longest line of descent runs back 5 generations to DEN070003 (2008). 2 later devices descend from it, 2 citing it directly.

  1. Root · 5 generations backDEN070003 Neurostar TMS SystemNeuronetics · 2008
  2. 4 generations backK083538 Neurostar TMS Therapy System, Model 1.1Neuronetics · 2008 · Recalled
  3. 3 generations backK122288 Brainsway Deep TMS SystemBrainsway, Ltd. · 2013
  4. 2 generations backK173540 Brainsway Deep (DTMS) SystemBrainsway, Ltd. · 2018
  5. 1 generation backK210201 Deep Transcranial Magnetic Stimulation (DTMS) SystemBrainsway, Ltd. · 2021
  6. This deviceK222196 Deep TMS SystemBrainsway, Ltd. · 2024
  7. Descendant · cites it directly · 0 of its ownK251391 BrainsWay Deep TMS SystemBrainsway, Ltd. · 2025
  8. Descendant · cites it directly · 0 of its ownK251449 BrainsWay Deep TMS SystemBrainsway, Ltd. · 2025

Most influential descendants

Showing 2 of 2 · See all
  • K251391BrainsWay Deep TMS SystemBrainsway, Ltd. · 2025 · cites it directly0descendants
  • K251449BrainsWay Deep TMS SystemBrainsway, Ltd. · 2025 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5DEN070003Neurostar TMS SystemNeuronetics2008—
−4K083538Neurostar TMS Therapy System, Model 1.1Neuronetics20081
−3K122288Brainsway Deep TMS SystemBrainsway, Ltd.2013—
−2K173540Brainsway Deep (DTMS) SystemBrainsway, Ltd.2018—
−1K210201Deep Transcranial Magnetic Stimulation (DTMS) SystemBrainsway, Ltd.2021—
0 (this device)K222196Deep TMS SystemBrainsway, Ltd.2024—
+1K251391BrainsWay Deep TMS SystemBrainsway, Ltd.2025—
+1K251449BrainsWay Deep TMS SystemBrainsway, Ltd.2025—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202520
FIG. 1 — Lineage of K222196, 2008–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OBP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new OBP device

  1. #1 K251119 MagVenture TMS Therapy Systemscore 21.8 · 11 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K210201Deep Transcranial Magnetic Stimulation (DTMS) System
Summary page 6
…evice Predicate Device: The subject device is a substantially equivalent to the BrainsWay Deep TMSTM Systems (Model 102 and 104) (“predicate device”) cleared in 510(k) K210201. Device Manufacturer 510(k) No. BrainsWay Deep TMSTM System…
Brainsway, Ltd.2021—

Also cleared against K210201: 2 other devices →

What descends from it? (2)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K251391BrainsWay Deep TMS SystemBrainsway, Ltd.20250
K251449BrainsWay Deep TMS SystemBrainsway, Ltd.20250

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 16 years and passes through 2 companies; a new generation was cleared every 3.3 years on median.
  • 1 of the 5 ancestors has a recall of any class.
  • Of its descendants, K251391 (Brainsway, Ltd., 2025) has gone furthest, with 0 descendants of its own.
  • 2 other devices also cite its predicate K210201.

How does its category compare?

All OBP devices

OBP Transcranial Magnetic Stimulator: FDA decisions, review times, recalls and adverse event reports over 20 years. 2024, this device’s year, is highlighted.

FDA decisions per year · OBP

12in 2025

2008: 22013: 22014: 12015: 22016: 32017: 82018: 42019: 32020: 12021: 52022: 62023: 72024: 52025: 122026 (partial year): 8
2007high 12 (2025) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OBP

125in 2025

2016: 101 days median2017: 73 days median2018: 144 days median2019: 156 days median2021: 132 days median2022: 168 days median2023: 119 days median2024: 266 days median2025: 125 days median2026 (partial year): 176 days median
2007high 266 (2024) · low 73 (2017)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · OBP

1in 2018

2009: 12018: 12026 (partial year): 1
2007high 1 (2009) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · OBP

81in 2025

2009: 32011: 52012: 32013: 12015: 32016: 62017: 32018: 62019: 122020: 122021: 152022: 592023: 432024: 502025: 81
2007high 81 (2025) · low 0 (2007)2025

MAUDE reports naming product code OBP, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20082—00
20090—13
20100—00
20110—05
20120—03
20132—01
20141—00
20152—03
2016310106
201787303
2018414416
20193156012
20201—012
20215132015
20226168059
20237119043
20245266050
202512125081
202681761—

What is it indicated for?

The BrainsWay Deep TMS™ System is indicated for the treatment of depressive episodes and for decreasing anxiety symptoms for those who may exhibit comorbid anxiety symptoms in adult patients suffering from Major Depressive Disorder (MDD) and who failed to achieve satisfactory improvement from previous antidepressant medication treatment in the current episode.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K222196: Deep TMS System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K222196

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026